Skip to main content

MoneyWorks4Me

Indoco Remedies informs about quarterly statement of investor complaint

12 Jan 2016 Evaluate

Indoco Remedies has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1894.95
Dr. Reddys Labs. 1394.05
Cipla 1409.50
Lupin 1986.95
Zydus Lifesciences 1195.45
View more..